Last reviewed · How we verify

NCT06637384

Effect of Hyaluronic Acid and Single Dose Corticosteroid Injection to Improve Wound Healing in Controlled Diabetic Patients Post Tooth Extraction.

Completed Phase 4 Last updated 15 October 2024
What this trial tests

Phase 4 trial testing Hyaluronic Acid (HA) in Diabetes Mellitus in 128 participants. Completed in 31 July 2024.

Timeline
1 March 2024
Primary endpoint
30 April 2024
31 July 2024

Quick facts

Lead sponsorRimsha Rasheed
PhasePhase 4
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposebasic science
Enrollment128
Start date1 March 2024
Primary completion30 April 2024
Estimated completion31 July 2024
Sites1 location across Pakistan

Drugs / interventions tested

Conditions studied

Sponsor

Rimsha Rasheed

Who can join

Adults 25 to 55, any sex, with Diabetes Mellitus or Wound Healing Delayed. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this clinical trial is to learn if hyaluronic acid and corticosteroid improves wound healing in diabetic patients after oral extraction.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Hyaluronic Acid (HA)

Trials testing the same drug.

Other recruiting trials for Diabetes Mellitus

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06637384.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing